利夫妥注射液

Pajjiż: Tajwan

Lingwa: Ċiniż

Sors: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Ingredjent attiv:

SODIUM BISULFITE (EQ TO SODIUM HYDROGEN SULFITE);;FRUCTOSE (LAEVULOSE);;MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O);;LACTIC ACID;;POTASSIUM PHOSPHATE ( eq to POTASSIUM PHOSPHATE DIBASIC);;SODIUM HYDROXIDE;;POTASSIUM CHLORIDE;;SODIUM CHLORIDE

Disponibbli minn:

信東生技股份有限公司 桃園市桃園區介壽路２２號 (43211700)

Kodiċi ATC:

B05BA10

Għamla farmaċewtika:

注射劑

Kompożizzjoni:

MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O) (4012001550) 0.30498MG; POTASSIUM CHLORIDE (4012001800) 1.26735MG; SODIUM CHLORIDE (4012002100) 0.2338MG; FRUCTOSE (LAEVULOSE) (4020000600) 100MG; POTASSIUM PHOSPHATE ( eq to POTASSIUM PHOSPHATE DIBASIC) (5612001900) 0.26127MG; SODIUM BISULFITE (EQ TO SODIUM HYDROGEN SULFITE) (6400000600) 0.41628MG; LACTIC ACID (9200005300) 2.07184MG; SODIUM HYDROXIDE (9600028200) 0.68017MG

Unitajiet fil-pakkett:

瓶裝;;盒裝

Klassi:

製　劑

Tip ta 'preskrizzjoni:

限由醫師使用

Manifatturat minn:

信東生技股份有限公司 桃園市桃園區豐林里介壽路２２號 TW

Żona terapewtika:

combinations

Indikazzjonijiet terapewtiċi:

取代含有葡萄糖或轉化糖液劑之治療及其他非經口的水、電解質之補給

Sommarju tal-prodott:

有效日期: 2024/12/16; 英文品名: LEFRUTOSE INJ. "S.T."

Data ta 'l-awtorizzazzjoni:

1987-12-16